Janis M Taube

Professor

19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Janis M Taube is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Skin Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

Lu, S., Stein, J. E., Rimm, D. L., Wang, D. W., Bell, J. M., Johnson, D. B., Sosman, J. A., Schalper, K. A., Anders, R. A., Wang, H., Hoyt, C., Pardoll, D. M., Danilova, L. & Taube, J. M., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalReview article

CD274 Antigen
Meta-Analysis
Biomarkers
Immunohistochemistry
Gene Expression Profiling

Correction: 33rd Annual meeting & pre-conference programs of the Society for Immunotherapy of Cancer (SITC 2018) (Journal for ImmunoTherapy of Cancer (2018) 6:Suppl 1 DOI: 10.1186/s40425-018-0422-y)

Berry, S., Giraldo, N., Nguyen, P., Green, B., Xu, H., Ogurtsova, A., Soni, A., Succaria, F., Wang, D., Roberts, C., Stein, J., Engle, E., Pardoll, A. M., Anders, R. A., Cottrell, T., Taube, J. M., Tran, B., Voskoboynik, M., Kuo, J., Bang, Y. L. & 72 others, Chung, H. C., Ahn, M. J., Kim, S. W., Perera, A., Freeman, D., Achour, I., Faggioni, R., Xiao, F., Ferte, C., Lemech, C., Meric-Bernstam, F., Werner, T., Hodi, S., Messersmith, W., Lewis, N., Talluto, C., Dostalek, M., Tao, A., McWhirter, S., Trujillo, D., Luke, J., Xu, C., Bomarelli, B., Qi, J., Qin, G., Yu, H., Jenkins, M., Lo, K. M., Halle, J. P., Lan, Y., Taylor, M., Vogelzang, N., Cohn, A., Stepan, D., Shumaker, R., Dutcus, C., Guo, M., Schmidt, E., Rasco, D., Brose, M., Di Simone, C., Jain, S., Richards, D., Encarnacion, C., Vogelzeng, N., Mier, J., An, J., Yang, Y. Y., Lee, W. H., Yang, J., Kim, J. K., Kim, H. G., Paek, S. H., Lee, J. W., Woo, J., Kim, J. B., Kwon, H., Lim, W., Paik, N. S., Kim, Y. K., Moon, B. I., Janku, F., Tan, D., Martin-Liberal, J., Takahashi, S., Geva, R., Gucalp, A., Chen, X., Subramanian, K., Mataraza, J., Wheler, J. & Bedard, P., Feb 13 2019, In : Journal for immunotherapy of cancer. 7, 1, 46.

Research output: Contribution to journalArticle

Open Access
Immunotherapy
Publications
Neoplasms
Consultants
Oncogenes
T-Lymphocytes
Conflict of Interest
Organized Financing

Different Biomarker Modalities and Response to Anti-PD-1/PD-L1 Therapies - Reply

Lu, S., Wang, H. & Taube, J. M., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalLetter

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Nghiem, P., Bhatia, S., Lipson, E., Sharfman, W., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., Boulmay, B. C., Riker, A. I., Burgess, M. A., Hanks, B. A., Olencki, T., Margolin, K., Lundgren, L. M., Soni, A., Ramchurren, N., Church, C. & 11 others, Park, S. Y., Shinohara, M. M., Salim, B., Taube, J. M., Bird, S. R., Ibrahim, N., Fling, S. P., Moreno, B. H., Sharon, E., Cheever, M. A. & Topalian, S., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 693-702 10 p.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Disease-Free Survival
Survival
Neoplasms
Merkel cell polyomavirus